Good response to second-line bevacizumab and interferon-alpha in a sunitinib ... - UroToday PDF Print
UroToday... such as bevacizumab, sunitinib, sorafenib, temsirolimus, and everolimus, the treatment of metastatic renal cell carcinoma has changed dramatically.

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.